Evidence map›Paper›PMID 39245656›Full record

ArticleScientific reports2024

Use of high-resolution fluorescence in situ hybridization for fast and robust detection of SARS-CoV-2 RNAs.

Jiapei Hu, Jiayi Hu, Li Jin, Dakang Hu, Philip K Nicholls, Tao Wang, Yonglin Ren, Dailun Hu, Bin Ma

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jiapei Hu *Tangshan Clinical Medical College, Hebei Medical University, Tangshan, Hebei, China.
Jiayi Hu *Tangshan Clinical Medical College, Hebei Medical University, Tangshan, Hebei, China.
Li Jin *Tangshan Clinical Medical College, Hebei Medical University, Tangshan, Hebei, China.
Dakang HuDepartment of Laboratory Medicine, Taizhou Municipal Hospital, Taizhou, Zhejiang, China.
Philip K NichollsSchool of Medical, Molecular and Forensic Sciences, Murdoch University, 90 South Street, Murdoch, WA, 6149, Australia.
Tao WangTelethon Kids Institute, Perth Children's Hospital, Nedlands, WA, Australia.
Yonglin RenSchool of Agricultural Science, Murdoch University, Murdoch, WA, Australia.
Dailun HuDepartment of Pathogenic Biology, Hebei Medical University, 361 Zhongshan East Road, Shijiazhuang, 050017, Hebei, China. 17300574@hebmu.edu.cn.
Bin MaSchool of Medical, Molecular and Forensic Sciences, Murdoch University, 90 South Street, Murdoch, WA, 6149, Australia. B.Ma@murdoch.edu.au.

Funding

Hebei Medical University 2022007, USIP2021111
6 · The paper itself

Abstract

Early, rapid, and accurate diagnostic tests play critical roles not only in the identification/management of individuals infected by SARS-CoV-2, but also in fast and effective public health surveillance, containment, and response. Our aim has been to develop a fast and robust fluorescence in situ hybridization (FISH) detection method for detecting SARS-CoV-2 RNAs by using an HEK 293 T cell culture model. At various times after being transfected with SARS-CoV-2 E and N plasmids, HEK 293 T cells were fixed and then hybridized with ATTO-labeled short DNA probes (about 20 nt). At 4 h, 12 h, and 24 h after transfection, SARS-CoV-2 E and N mRNAs were clearly revealed as solid granular staining inside HEK 293 T cells at all time points. Hybridization time was also reduced to 1 h for faster detection, and the test was completed within 3 h with excellent results. In addition, we have successfully detected 3 mRNAs (E mRNA, N mRNA, and ORF1a (-) RNA) simultaneously inside the buccal cells of COVID-19 patients. Our high-resolution RNA FISH might significantly increase the accuracy and efficiency of SARS-CoV-2 detection, while significantly reducing test time. The method can be conducted on smears containing cells (e.g., from nasopharyngeal, oropharyngeal, or buccal swabs) or smears without cells (e.g., from sputum, saliva, or drinking water/wastewater) for detecting various types of RNA viruses and even DNA viruses at different timepoints of infection.

Indexed as

COVID-19In Situ Hybridization, FluorescenceRNA, ViralSARS-CoV-2Coronavirus Envelope ProteinsCoronavirus Nucleocapsid ProteinsHEK293 CellsHumansPhosphoproteinsRNA, MessengerCoronavirus Envelope ProteinsCoronavirus Nucleocapsid Proteinsenvelope protein, SARS-CoV-2nucleocapsid phosphoprotein, SARS-CoV-2PhosphoproteinsRNA, MessengerRNA, ViralCOVID-19Fluorescence in situ hybridizationInfectionmRNARNA virusSARS-CoV-2

Identifiers

PMID39245656
PMCPMC11381525

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.